Another observational study of 32 adults and children with CF and ABPA showed that posaconazole treatment (but not itraconazole or voriconazole) was associated with a significant reduction of Aspergillus-specific IgE (Table 3) [193]. Here, IGHE is linked to cystic fibrosis.